The main objective of this protocol is to measure the improvement of the overall situation of patients with diffuse chronic pain or fibromyalgia to 12 weeks by non-drug treatment relaxation.

Secondarily,is to evaluate the evolution of physical variables, psychological and social improvement of the quality of life. To evaluate the evolution of drug consumption

Inclusion Criteria:

• Men or women over 18 years
• established diagnosis of fibromyalgia as defined by the American College of Rheumatology: widespread pain and eleven tender points at 18 sites listed (ACR, 1990)
• EVA ≥ 4 (on a scale of 10 cm)
• no change in treatment for 15 days, except for treatment "on demand" or "rescue"
• patient has given its written consent
• patient wishing to benefit from relaxation sessions
• people who can meet the self-assessment and hetero-assessment
• people with a social security number

Exclusion Criteria:

• any painful situation that cannot be distinguished from fibromyalgia pain by the patient
• patients untreated or treated for less than a month
• patient with psychosis or severe depression or severe anxiety or impulsivity characterized, at the discretion of the clinician.
• patients receiving benzodiazepines at the request
• patient with deafness
• patient after a body treatment using a relaxation method, relaxation therapy or hypnosis